Background: Venous thromboembolism (VTE) exerts a considerable burden on the health care systems. Although many practice guidelines have been developed regarding prophylaxis and treatment of venous thromboembolism, there is a large gap between the recommendations and the medical practice in health care centers. In this study, we tried to assess adherence of the medical team to guidelines for venous thromboprophylaxis in medical and surgical wards of teaching hospitals affiliated to Shiraz University of Medical Sciences.
INTRODUCTION
Pulmonary embolism (PE) and deep vein thrombosis (DVT), collectively known as VTE, are significant causes of disability and death around the world. VTE is the most common vascular disease following acute myocardial infarction and stroke having an estimated annual incidence of 0.1% and affecting 2% to 5% of the population during their lifetimes (1) .
TANAFFOS
VTE exerts considerable burden on the health care systems (2, 3) . As an example, VTE resulted in approximately 300,000 hospitalizations and at least 50,000 deaths per year in the United States in 2005 (4, 5) . In addition, among patients adequately treated for VTE, thromboembolism may recur in 5% at three months and up to 30% at eight years (6, 7) . It has been suggested that, in DVT patients alone, nearly $500,000 in health care costs could be prevented per 100 patients per year if patients were properly screened and treated, emphasizing the importance of timely screening and treatment of VTE (2) .
Although many practice guidelines have been developed regarding prophylaxis and treatment of VTE (8) , there is a large gap between the recommendations and the medical practice in health care centers (9) (10) (11) . Even though many strategies have been proposed to improve the practice of VTE prophylaxis and treatment, it remains suboptimal (12) (13) (14) . In Iran, as in many other developing countries, little information describing adherence to VTE prophylaxis and treatment is available. It seems that strategies to increase the compliance to VTE prophylaxis and treatment guidelines should be evaluated in order to ensure patient safety. To our knowledge, there are few studies on the adherence of medical centers to proper prophylactic and therapeutic practice of antithrombotics in the Iranian hospitals (15,16).
Therefore, the present study was designed as a crosssectional descriptive study with the aim of evaluating adherence to the 9 th edition of ACCP guidelines for VTE prophylaxis in medical and surgical inpatients in teaching hospitals affiliated to Shiraz University of Medical Sciences.
MATERIALS AND METHODS
In this cross-sectional descriptive study, the duration of study was 4 months from February 2014 to May 2014. The study protocol was approved by the Ethical Committee of Shiraz University of Medical Sciences.
A total number of 500 patients were recruited among hospitalized patients in neurosurgery, orthopedics, general surgery, internal medicine and obstetrics & gynecology departments and surgical and medical intensive care units.
The number of study subjects for enrollment was based on the objectives of our study with consideration of previous reports and presumption of a 5% error, 80% power and 10% quantity of effect. Subjects were selected using convenience sampling. The inclusion criteria were:
 Hospitalization more than 3 days in a certain ward.
 Negative history of receiving oral or intravenous anticoagulation therapy with indications other than thromboprophylaxis.
Patients with the following criteria were excluded:
 Patients under 16 years of age.
 Patients who had received recent fibrinolytic therapy.
Overall, 472 individuals were considered eligible for enrollment.
Measurements and Data Collection
Two data gathering forms with three parts were designed in order to obtain data from records of the studied individuals in surgical and non-surgical wards. In the first part, demographic characteristics of the studied 
Statistical Analysis
Abstracted data were coded and entered into statistical prophylaxis was not apparently used in the studied wards (Table 3) . 
DISCUSSION
VTE prophylaxis has shown to be the number one patient safety intervention in patients at risk.
Thromboprophylaxis reduces adverse patient outcomes, is safe and decreases the overall costs (17).
As mentioned earlier, more than 90% of the studied patients had indications to receive thromboprophylaxis according to the ACCP guidelines, which indicates that a relatively high-risk patient population was studied here.
Other studies have reported a range of 75-80% for patients We reported an overall appropriateness rate of 45.1%, which is within the reported range of 3%-91% in different studies around the world (10, 11, (15) (16) (27) (28) (29) (30) . Excluding those studies with a very low or very high rate of appropriateness, most of the reports are within a range of 30-60% for VTE prophylaxis appropriateness (10) including our own study.
Other studies have also declared that the most common LMHW was the most commonly used form of pharmacologic prophylaxis in total (39.3%), followed by UFH (24.6%) and no prophylaxis (39.5%). However a comparison between the studied wards revealed that, only in the internal medicine wards, patients had received UFH more commonly compared to LMWH (60.2% vs. 10.6%).
Overall, these findings are compatible with the existing literature and are suggestive of a safety benefit with LMWH compared with UFH (33, 34) . The relatively lower cost of UFH compared to LMHW explains why UFH was prescribed more commonly in the internal medicine wards.
For the remaining surgical wards including orthopedics, LMWH was practiced more commonly than UFH as the ACCP guidelines recommend the use of LMWH for orthopedic surgery prophylaxis, emphasizing that the risk of heparin-induced thrombocytopenia is lower with LMWH prophylaxis than with UFH prophylaxis (35) . It should be mentioned that in surgical wards and specifically orthopedics we could not monitor the post operation status of patients regarding receiving thromboprophylaxis after being discharged from the hospital. It seems that duration of prophylaxis was not long enough in these patients.
Appropriateness of VTE prophylaxis in different risk
levels is another important aspect of our findings yet to be discussed. We indicated that high-risk patients had a greater rate of appropriateness compared to individuals in lower risk levels (55.2% vs. 22.1%). We hypothesize that this finding is mainly due to the fact that the majority of we propose that educational initiatives should be taken into consideration to increase the awareness and understanding of management guidelines in our teaching hospitals (26).
Strengths and Limitations
Our study was the first cross-sectional descriptive study conducted in the Southern part of Iran regarding the appropriateness of VTE prophylaxis and adherence to guidelines. We studied a variety of different medical and surgical wards and made a comparison among these wards. Moreover, three different hospitals were included in the analysis, which increased the impact of our findings.
There were a number of potential limiting factors in our study. Relatively small number of studied subjects compared to the Western studies can be mentioned as the most important limitation. We did not investigate specifically appropriate duration of thromboprophylaxis.
Considering the small number of individuals with thromboembolic events, we could not draw associations between appropriateness of VTE prophylaxis and rate of DVT and further studies are required. Finally, it was not possible to determine the exact reasons underlying the lack of prescription of thromboprophylaxis for patients in whom prophylaxis was indicated.
CONCLUSION
The 
